drugset / Trial / NCT07183787

Letrozole vs Danazol for Endometriosis-Related Pain: Randomized Trial

NCT07183787

Phase 2 Completed 60 enrolled Sidra Salman
RandomizedFactorialOpen-labelTreatment

Summary

Background: Endometriosis is a chronic gynecological condition defined by the ectopic presence of endometrial glands and stroma outside the uterine cavity, most commonly diagnosed via laparoscopy. While its exact etiology remains uncertain, a positive family history is considered a significant risk factor. Danazol has historically demonstrated efficacy in alleviating endometriosis-related pain, while letrozole, primarily used in neoadjuvant settings, has recently emerged as a promising alternative. This study aimed to compare the mean reduction in pain scores between letrozole and danazol in women with laparoscopically confirmed endometriosis. Objective: To compare the efficacy of letrozole versus danazol in reducing pain scores among women diagnosed with endometriosis. Material \& Methods: Study Design: Randomized control trial Setting: Department of Obstetrics \& Gynaecology, Sharif Medical and Dental Hospital

Timeline

Start
2019-04-10
Primary completion
2019-10-10
Completion
2025-07-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Danazol Other / unclassified 200 mg Oral
Subject Letrozole Other / unclassified 2.5 mg Oral

Indications